Chafic Chebli

Title: Chafic Chebli: Innovator in Pharmaceutical Drug Release

Introduction

Chafic Chebli is a notable inventor based in Dollard des Ormeaux, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drug release technologies. His innovative approach has led to the creation of a unique sustained release matrix that enhances the effectiveness of oral medications.

Latest Patents

Chafic Chebli holds a patent for "Substituted amylose as a matrix for sustained drug release." This invention involves a pharmaceutical sustained release tablet designed for oral administration. The tablet is composed of a compressed blend of at least two dry powders, including a pharmaceutical drug and a sustained release matrix. The matrix is made from substituted amylose, which is prepared by reacting amylose with an organic substituent in a basic medium. This innovative matrix allows for a controlled and sustained release of the drug, achieving a remarkable close-to-linear release profile over a period of 9 to 20 hours. He has 1 patent to his name.

Career Highlights

Chafic Chebli is affiliated with the Université de Montréal, where he continues to advance his research in pharmaceutical sciences. His work focuses on improving drug delivery systems, which can significantly impact patient care and treatment outcomes.

Collaborations

Chafic has collaborated with esteemed colleagues, including Louis Cartilier and Iskandar Moussa. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical field.

Conclusion

Chafic Chebli's contributions to pharmaceutical technology through his innovative patent demonstrate his commitment to improving drug delivery systems. His work has the potential to transform how medications are administered and absorbed, ultimately benefiting patients worldwide.